- Report
- February 2026
- 250 Pages
Global
From €4023EUR$4,490USD£3,446GBP
- Report
- January 2026
- 189 Pages
Global
From €3176EUR$3,545USD£2,721GBP
€3529EUR$3,939USD£3,023GBP
- Report
- February 2026
- 250 Pages
Global
From €4023EUR$4,490USD£3,446GBP
- Report
- August 2026
- 50 Pages
Global
From €2374EUR$2,650USD£2,034GBP
- Report
- August 2026
- 50 Pages
Global
From €2374EUR$2,650USD£2,034GBP
- Report
- June 2026
- 187 Pages
Global
From €3176EUR$3,545USD£2,721GBP
€3529EUR$3,939USD£3,023GBP
- Report
- February 2026
- 250 Pages
Global
From €4023EUR$4,490USD£3,446GBP
- Report
- February 2026
- 250 Pages
Global
From €4023EUR$4,490USD£3,446GBP
- Report
- February 2026
- 250 Pages
Global
From €4023EUR$4,490USD£3,446GBP
- Report
- February 2026
- 250 Pages
Global
From €4023EUR$4,490USD£3,446GBP
- Report
- February 2026
- 250 Pages
Global
From €4023EUR$4,490USD£3,446GBP
- Report
- February 2026
- 250 Pages
Global
From €4023EUR$4,490USD£3,446GBP
- Report
- February 2026
- 250 Pages
Global
From €4023EUR$4,490USD£3,446GBP
- Report
- February 2026
- 250 Pages
Global
From €4023EUR$4,490USD£3,446GBP
- Report
- August 2026
- 282 Pages
Global
From €5242EUR$5,850USD£4,490GBP
- Report
- March 2026
- 250 Pages
Global
From €4023EUR$4,490USD£3,446GBP
- Report
- February 2026
- 250 Pages
Global
From €4023EUR$4,490USD£3,446GBP
- Report
- February 2026
- 250 Pages
Global
From €4023EUR$4,490USD£3,446GBP
- Report
- February 2026
- 200 Pages
Global
From €7159EUR$7,990USD£6,132GBP
- Report
- May 2026
- 400 Pages
Global
From €4434EUR$4,949USD£3,798GBP

Albuterol is a medication used to treat and prevent bronchospasm in people with asthma, chronic obstructive pulmonary disease (COPD), and other breathing disorders. It is a short-acting β2-adrenergic receptor agonist, which works by relaxing the muscles of the airways and increasing airflow to the lungs. Albuterol is available in both oral and inhaled forms, and is often used in combination with other medications to treat respiratory conditions.
Albuterol is one of the most commonly prescribed respiratory drugs, and is widely used in both the United States and Europe. It is available in both generic and brand-name formulations, and is often used in combination with other medications to treat asthma and COPD. In addition, albuterol is used to treat acute exacerbations of COPD, and is also used to prevent exercise-induced bronchospasm.
Some companies in the Albuterol market include GlaxoSmithKline, Merck, Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more